Study for the effect of Huatan Quyu prescription in the treatment of the patients with cerebral small vascular disease

Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Meet the diagnostic criteria of cerebral small vascular disease; ? It conforms to the diagnostic criteria of phlegm and blood stasis syndrome of apoplexy; ? = 18 years old =80 years old, no gender limitation; ?3 points =NIHSS score =6 points; ? The patient is conscious, the crude determination of the force, attention, memory and other basic normal, with examination adhere to the treatment; ? The patient or legal representative agrees and signs the informed consent

•? Patients receiving intravenous thrombolysis; ? Magnetic resonance angiography (MRA) showed obvious stenosis or occlusion of intracranial large vessels; ? Unable to complete the examination, such as consciousness impairment, hearing impairment, etc.; (4) suffering from diseases involving central nervous system, such as multiple sclerosis, carbon monoxide poisoning and other causes of white matter abnormalities; (5) Subcortical infarction or watershed infarction, subcortical infarction lesions > 20mm; ? Hereditary small vascular disease, previous history of cerebral hemorrhage or large area of cerebral infarction, atrial fibrillation; ? Patients with severe liver and renal insufficiency (note: Liver dysfunction refers to ALT or AST greater than 2 times the normal upper limit; Renal insufficiency (Cr > 2 times normal upper limit), hematopoietic system, tumor and other serious primary diseases and psychiatric patients. MRI scan contraindications or unable to scan; ? Pregnant or lactating women.

发起方

Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine